Sangamo Therapeutics Inc Free Cash Flow Generation Index
Sangamo Therapeutics Inc free cash flow generation index. Sangamo Therapeutics Inc (SGMO) has a Free Cash Flow Generation Index of 0.99x as of September 2024. Free cash flow of $11.64 Million represents 1% of operating cash flow ($11.76 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sangamo Therapeutics Inc (2017–2020)
Free cash flow generation index of Sangamo Therapeutics Inc from 2017 to 2020. Historical FCF Generation Index trend for Sangamo Therapeutics Inc across 3 annual periods. See Sangamo Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Sangamo Therapeutics Inc Free Cash Flow Generation Index by Year (2017–2020)
Sangamo Therapeutics Inc free cash flow generation index by year from 2017 to 2020. Year-by-year Free Cash Flow Generation Index for Sangamo Therapeutics Inc. For the full cash flow conversion analysis, see SGMO cash flow metrics.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.91x | $155.16 Million | $169.88 Million | $14.71 Million | ▲ +673.9% |
| 2018 | -0.16x | $-5.91 Million | $37.15 Million | $43.06 Million | ▼ -124.0% |
| 2017 | 0.66x | $7.43 Million | $11.18 Million | $3.75 Million | — |